Tumour samples were chosen to represent the major breast cancer subtypes: oestrogen receptor-positive and progesterone receptor-positive, oestrogen receptor-positive and progesterone receptor-negative, oestrogen receptor/progesterone receptor/ErbB2-positive, and oestrogen receptor-negative and progesterone receptor-negative (Additional data file 4). This evidence concerns the gene ERBB2 and breast cancer.